Your browser doesn't support javascript.
loading
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.
Friedberg, Jonathan W; Forero-Torres, Andres; Bordoni, Rodolfo E; Cline, Vivian J M; Patel Donnelly, Dipti; Flynn, Patrick J; Olsen, Gregg; Chen, Robert; Fong, Abraham; Wang, Yinghui; Yasenchak, Christopher A.
Afiliación
  • Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Forero-Torres A; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Bordoni RE; Georgia Cancer Specialists, Marietta, GA.
  • Cline VJM; Texas Oncology-Round Rock Seton Williamson, Round Rock, TX.
  • Patel Donnelly D; Virginia Cancer Specialists, Fairfax, VA.
  • Flynn PJ; Minnesota Oncology, Woodbury, MN.
  • Olsen G; Providence Saint Joseph Medical Center, Burbank, CA.
  • Chen R; City of Hope Medical Center, Duarte, CA.
  • Fong A; Seattle Genetics, Inc., Bothell, WA; and.
  • Wang Y; Seattle Genetics, Inc., Bothell, WA; and.
  • Yasenchak CA; Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR.
Blood ; 130(26): 2829-2837, 2017 12 28.
Article en En | MEDLINE | ID: mdl-29038340

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados / Dacarbazina / Clorhidrato de Bendamustina Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados / Dacarbazina / Clorhidrato de Bendamustina Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article